SIRT1 and intervertebral disk degenerative disorder: These effects are mediated by SIRT1-dependent modulation of the NF-κB/FOXO3 pathway, suggesting the potential of tyrosol as a therapeutic agent for delaying IDD progression (Qi et al., 2020).